Gregorio Benites-Narcizo

Mr. Gregorio Benites-Narcizo

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NGNadia Galindo-Cabello
Nadia Galindo-Cabello
ECEstefanía Caballano-Infantes
Estefanía Caballano-Infantes
GBGregorio Benites-Narcizo
Gregorio Benites-Narcizo
Salvador Pastor-IdoateSalvador Pastor-Idoate
Salvador Pastor-Idoate
Francisco J. Diaz CorralesFrancisco J. Diaz Corrales
Francisco J. Diaz Corrales
Ricardo Usategui-MartínRicardo Usategui-Martín
Ricardo Usategui-Martín
Retinal degenerative diseases (RDDs) comprise diverse genetic and phenotypic conditions that cause progressive retinal dysfunction and cell loss, leading to vision impairment or blindness. Most RDDs lack appropriate animal models for their study, which affects understanding their disease mechanisms and delays the progress of new treatment development. Recent advances in stem cell engineering, omics, and organoid technology are facilitating research into diseases for which there are no previously existing models. The development of retinal organoids produced from human stem cells has impacted the study of retinal development as well as the development of in vitro models of diseases, opening possibilities for applications in regenerative medicine, drug discovery, and precision medicine. In this review, we recapitulate research in the retinal organoid models for RDD, mentioning some of the main pathways underlying retinal neurodegeneration that can be studied in these new models, as well as their limitations and future challenges in this rapidly advancing field.

6 January 2025 in Journal of NeuroInterventional Surgery
Verified
Journal Article
Closed access
PDF file
WTWondwossen Tekle
Wondwossen Tekle
GBGregorio Benites-Narcizo
Gregorio Benites-Narcizo
SMSamantha Miller
Samantha Miller
ABAlejandro Betancourt
Alejandro Betancourt
AHAmeer E. Hassan
Ameer E. Hassan
Background There is growing interest and evidence in spontaneous intracerebral hemorrhage (ICH) evacuation with minimally invasive surgery (MIS). If early ICH evacuation becomes the standard of care, training neurointerventionalists to perform MIS would expand global access to treatment. We present a retrospective analysis of patients who underwent MIS–ICH evacuation performed by interventional neurologists in collaboration with neurosurgeons. Method Patients meeting prespecified criteria underwent MIS–ICH evacuation using the Artemis (Penumbra) by an interventional neurologist–neurosurgeon team. Baseline demographic, clinical, and radiographic characteristics were collected. Procedure location was recorded. The primary outcome of interest was the rate of symptomatic rebleeding. Secondary outcomes included hematoma reduction, serious adverse events, length of stay, disposition, and discharge and 6 month functional status. Results 19 patients were included in this analysis. One third of cases were performed in the neuroangiography suite using intraprocedural flat panel CT and the rest were performed in the operating room. All were performed under neuronavigation using AxiEM (Medtronic-Stealth-Station). There was a median 80% hematoma reduction from a median preoperative ICH volume of 31.1 mL (IQR 26.2–56.4). A post-procedural hematoma volume of <15 mL was achieved in 67% of cases, comparable with that seen in the ENRICH (Early Minimally Invasive Removal of Intracerebral Hemorrhage) trial (72.7%). No patients developed symptomatic post-procedural hematoma expansion. Conclusion This study suggests that MIS–ICH evacuation can be performed safely and effectively by trained neurointerventionalists. Our experience also supports the ability to perform MIS–ICH evacuation in the neuroangiography suite. We advocate for the development of a standardized neurointerventional training protocol and certification pathway for the performance of MIS–ICH evacuation with the goal of improving global access to care.

29 July 2023 in Life
Verified
Journal Article
Open access
PDF file
GBGregorio Benites-Narcizo
Gregorio Benites-Narcizo
JUJure Urbančič
Jure Urbančič
CBCarolina Bardales
Carolina Bardales
Domen VozelDomen Vozel
Domen Vozel
This paper presents a literature review and a case of an 83-year-old otherwise healthy female patient with a history of recent syncope, a sudden-onset right-sided temporal headache, diplopia, and vision loss. An exam revealed right-sided upper eyelid ptosis, myosis, vision loss, ophthalmoplegia, and a positive relative afferent pupillary defect on the right eye. CT showed sphenoid sinus opacification, eroded lateral sinus wall, Vidian canal, disease extension to the posterior ethmoid air cells, orbital apex, medial orbital wall, and pterygopalatine fossa. An orbital apex syndrome (Jacod’s syndrome), Horner syndrome, and pterygopalatine fossa infection were diagnosed due to the acute invasive fungal sinusitis developed from a sphenoid sinus fungal ball. The patient was treated with antimicrobial therapy and transnasal endoscopic surgery twice to decompress the orbital apex, drain the abscess and obtain specimens for analysis. The right-sided ptosis, visual loss, ophthalmoplegia, and headache resolved entirely. No immune or comorbid diseases were identified, microbiological and histopathological analyses were negative, and MRI could not be performed on the presented patient. For that reason, the diagnostic procedure was non-standard. Nevertheless, the treatment outcome of this vision and life-threatening disease was satisfactory. Treating the fungal ball in an older or immunocompromised patient is essential to prevent invasive fungal rhinosinusitis and fatal complications.

7 August 2025 in Acta Ophthalmologica
Verified
Journal Article
Open access
Salvador Pastor-IdoateSalvador Pastor-Idoate
Salvador Pastor-Idoate
Pablo Redruello-GuerreroPablo Redruello-Guerrero
Pablo Redruello-Guerrero
LHLaura de Juan Hernández
Laura de Juan Hernández
GBGregorio Benites-Narcizo
Gregorio Benites-Narcizo
MRMario Rivera-Izquierdo
Mario Rivera-Izquierdo
JPj Pastor
j Pastor
Purpose: This systematic review aims to evaluate and synthesize the existing literature on the interventions used for submacular haemorrhage ( SMH ), highlighting the controversies and differences in clinical practice. Method: A systematic review was conducted following the PRISMA guidelines. A comprehensive search was performed across multiple databases, including MEDLINE , EMBASE and Cochrane Library, to identify studies on SMH treatment. Inclusion criteria encompassed randomized controlled trials, cohort studies and case series that focused on different therapeutic interventions. Data on functional outcomes, efficacy and safety of the interventions were extracted and analysed. Results: The review included 150 studies, of which 38 were included in the network meta‐analysis. The analysis of best corrected visual acuity ( BCVA ) Included 26 studies, 20 interventions and 2125 eyes. Heterogeneity was moderate ( I 2 = 28.9%). Non‐vitrectomy therapies showed better BCVA outcomes and fewer complications (e.g. retinal detachment, vitreous haemorrhage), while vitrectomy‐based treatments achieved better anatomical results. According to P ‐score ranking, “Observation” had the highest probability of being most effective for BCVA ( P ‐score = 0.8051), followed by anti‐ VEGF monotherapy and non‐vitrectomy combinations. However, this result should be interpreted cautiously, as the “Observation” group was based on only two studies (26 eyes) with clinical heterogeneity. No publication bias was detected (Egger's test p = 0.582). Conclusions: There is no consensus on a standard evidence‐based treatment for SMH . Minimally invasive strategies are promising, but factors such as timing, lesion size and anti‐ VEGF use remain critical. Further large‐scale randomised trials are needed to define optimal management.